MPO and Guillain-Barre syndrome: Interestingly, in the absence of cathelicidin, we saw an enhancement of neutrophil MPO release (Fig. 4), which may explain the reduction in GBS CFU levels compared to those of WT mice, but the molecular factors promoting this neutrophil response are beyond the scope of this study.